wtls2 imdbpae
Name
xoi2
Label
Xanthine Oxidase Inhibitors (SHHS2)
Description

Participant taking XANTHINE OXIDASE INHIBITORS within two weeks of the SHHS2 visit. All medications were recorded during the interview, and medication information was later categorized by physician review.

Domain
noyes01
  • 0: No
  • 1: Yes
  • 8: Don't know
Type
choices
Tags
gout hyperuricemia XOI2
Xanthine Oxidase Inhibitors (SHHS2) vs SHHS Visit Number
Visit 1 Interim Follow-up Visit Visit 2 CVD Outcomes
Total - - 4,080 -
No - - 3,544 -
Yes - - 76 -
Don't know - - - -
Unknown - - 460 -
Xanthine Oxidase Inhibitors (SHHS2) vs Age at SHHS1
Visit 2
35-44 years 45-54 years 55-64 years 65-74 years 75-84 years 85 years or older Total
Total 184 707 1,321 1,200 624 44 4,080
No 170 644 1,128 1,028 534 40 3,544
Yes 6 3 20 28 19 - 76
Don't know - - - - - - -
Unknown 8 60 173 144 71 4 460
Xanthine Oxidase Inhibitors (SHHS2) vs Gender
Visit 2
Male Female Total
Total 1,861 2,219 4,080
No 1,604 1,940 3,544
Yes 57 19 76
Don't know - - -
Unknown 200 260 460
Xanthine Oxidase Inhibitors (SHHS2) vs Race
Visit 2
White Black Other Total
Total 3,587 256 237 4,080
No 3,094 236 214 3,544
Yes 68 6 2 76
Don't know - - - -
Unknown 425 14 21 460